Frequency of Biological Drug Use in Older Patients with Immune-Mediated Inflammatory Diseases: Results from the Large-Scale Italian VALORE Distributed Database Network

This study documented a significant rise in biological drug use among older patients with IMID in Italy over the last decade. Around 50% of users discontinued treatment after the first year, with even higher rates observed in very old patients with polypharmacy. These findings highlight potential concerns about the use of biological therapies in older patients and underscore the urgent need for large-scale cohort studies to address the current knowledge gaps regarding their safety and effectiveness in this vulnerable population.

Authors

Institutions

Publication Details

Journal
BioDrugs
Published
2025-04-03
DOI
https://doi.org/10.1007/s40259-025-00716-2
Citations
2
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
3.34

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Frequency of Biological Drug Use in Older Patients with Immune-Mediated Inflammatory Diseases: Results from the Large-Scale Italian VALORE Distributed Database Network

Ester Sapigni, Sebastiano Addario Pollina, Annalisa Campomori, Valeria Belleudi et al.
2 citations
BioDrugs
Systemic Lupus Erythematosus Research
3.34
article

Frequency of Biological Drug Use in Older Patients with Immune-Mediated Inflammatory Diseases: Results from the Large-Scale Italian VALORE Distributed Database Network

Ester Sapigni, Sebastiano Addario Pollina, Annalisa Campomori, Valeria Belleudi, Luca L’Abbate, Ylenia Ingrasciotta, Marco Massari, Aurora Puccini, Martina Zanforlini, Giampaolo Bucaneve, Giorgia Pellegrini, Paolo Carta, Ilenia Senesi, Anna Cavazzana, Stefania Spila Alegiani, Sara Lopes, Chiara Bellitto, Silvana Anna Maria Urru, Marco Tuccori, Stefano Ledda, Gianluca Trifirò, Carla Sorrentino, Olivia Leoni, Paolo Stella, Alessandra Allotta, Giovambattista De Sarro, Rosa Gini, Andrea Spini, Lucian Ejlli, Angela Scapin, Paola Rossi, Giorgio Costa, Roberto Da, Clément Mathieu, Antea Maria Pia Mangano, Federica Soardo, Rita Francesca Scarpelli, Francesco Balducci
article en
2 citations

Abstract

This study documented a significant rise in biological drug use among older patients with IMID in Italy over the last decade. Around 50% of users discontinued treatment after the first year, with even higher rates observed in very old patients with polypharmacy. These findings highlight potential concerns about the use of biological therapies in older patients and underscore the urgent need for large-scale cohort studies to address the current knowledge gaps regarding their safety and effectiveness in this vulnerable population.

BioDrugsVol. 39(3)
University of Verona (IT), University of Teramo (IT), Université de Bordeaux (FR), Inserm (FR), Magna Graecia University (IT), Bordeaux Population Health (FR), Provincia Autonoma di Trento (IT), Agenzia Sanitaria e Sociale Regionale (IT), Regione Siciliana (IT), Regione Puglia (IT), National Observatory (BR), Accademia di Belle Arti di Catanzaro (IT), Regione del Veneto (IT), Agenzia Regionale di Sanità della Toscana (IT), Agenzia Sanitaria Regionale Abruzzo (IT), Regione Emilia-Romagna, Regione Autonoma della Sardegna, Regione Autonoma Friuli Venezia Giulia (IT), Regione Umbria
Università degli Studi di Verona, Agenzia Italiana del Farmaco, Ministero della Salute
Good health and well-being
Openalex Percentile: Top 9%
Systemic Lupus Erythematosus Research
3.34
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.